$ALT
Altimmune, Inc.

2020 Q1 Form 10-Q Financial Statement

#000156459020025123 Filed on May 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $2.210M $2.956M
YoY Change -25.23% 9.83%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.330M $2.070M
YoY Change 12.56% -15.51%
% of Gross Profit
Research & Development $7.188M $3.218M
YoY Change 123.38% -44.01%
% of Gross Profit
Depreciation & Amortization $73.36K $61.28K
YoY Change 19.71% 144.5%
% of Gross Profit
Operating Expenses $9.519M $5.284M
YoY Change 80.15% -39.16%
Operating Profit -$7.307M -$2.329M
YoY Change 213.79% -61.16%
Interest Expense $1.885K $740.00
YoY Change 154.73% -14.94%
% of Operating Profit
Other Income/Expense, Net $175.2K $231.3K
YoY Change -24.23% -87.36%
Pretax Income -$7.132M -$2.097M
YoY Change 240.03% -49.65%
Income Tax -$3.246M $0.00
% Of Pretax Income
Net Earnings -$3.886M -$2.097M
YoY Change 85.27% -33.91%
Net Earnings / Revenue -175.82% -70.96%
Basic Earnings Per Share
Diluted Earnings Per Share -$257.4K -$221.3K
COMMON SHARES
Basic Shares Outstanding 15.36M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.90M $44.30M
YoY Change -25.73% 863.04%
Cash & Equivalents $11.31M $44.30M
Short-Term Investments $21.60M
Other Short-Term Assets $700.0K $1.100M
YoY Change -36.36% -77.55%
Inventory
Prepaid Expenses
Receivables $2.000M $2.900M
Other Receivables $4.000M $1.100M
Total Short-Term Assets $39.60M $49.41M
YoY Change -19.86% 148.05%
LONG-TERM ASSETS
Property, Plant & Equipment $1.700M $1.283M
YoY Change 32.53% -6.7%
Goodwill
YoY Change
Intangibles $13.76M
YoY Change -65.02%
Long-Term Investments
YoY Change
Other Assets $100.0K $169.9K
YoY Change -41.14% -24.53%
Total Long-Term Assets $14.60M $15.96M
YoY Change -8.52% -61.02%
TOTAL ASSETS
Total Short-Term Assets $39.60M $49.41M
Total Long-Term Assets $14.60M $15.96M
Total Assets $54.20M $65.37M
YoY Change -17.09% 7.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $900.0K $14.75K
YoY Change 6000.45% -97.13%
Accrued Expenses $5.116M $3.435M
YoY Change 48.95% -24.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K
YoY Change
Total Short-Term Liabilities $6.000M $3.676M
YoY Change 63.2% -28.68%
LONG-TERM LIABILITIES
Long-Term Debt $1.791M $2.317M
YoY Change -22.69% 286.14%
Other Long-Term Liabilities $115.2K $235.1K
YoY Change -51.0% -92.65%
Total Long-Term Liabilities $1.906M $2.552M
YoY Change -25.3% -32.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.000M $3.676M
Total Long-Term Liabilities $1.906M $2.552M
Total Liabilities $12.30M $6.052M
YoY Change 103.25% -57.89%
SHAREHOLDERS EQUITY
Retained Earnings -$119.0M
YoY Change 47.11%
Common Stock $1.313K
YoY Change -40.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $41.90M $59.32M
YoY Change
Total Liabilities & Shareholders Equity $54.20M $65.37M
YoY Change -17.09% 7.4%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$3.886M -$2.097M
YoY Change 85.27% -33.91%
Depreciation, Depletion And Amortization $73.36K $61.28K
YoY Change 19.71% 144.5%
Cash From Operating Activities -$4.347M -$2.113M
YoY Change 105.76% -40.63%
INVESTING ACTIVITIES
Capital Expenditures $18.13K $1.226K
YoY Change 1378.87% -99.81%
Acquisitions
YoY Change
Other Investing Activities $6.600M $0.00
YoY Change
Cash From Investing Activities $6.563M -$4.246K
YoY Change -154674.09% -99.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 96.71K 12.70M
YoY Change -99.24% 68588.38%
NET CHANGE
Cash From Operating Activities -4.347M -2.113M
Cash From Investing Activities 6.563M -4.246K
Cash From Financing Activities 96.71K 12.70M
Net Change In Cash 2.313M 10.58M
YoY Change -78.15% -351.38%
FREE CASH FLOW
Cash From Operating Activities -$4.347M -$2.113M
Capital Expenditures $18.13K $1.226K
Free Cash Flow -$4.366M -$2.114M
YoY Change 106.49% -49.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
28
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12668784
CY2019Q1 alt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
30324
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
59322110
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-3885649
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-2097306
CY2020Q1 alt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
39974
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
48312566
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
407714
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7306754
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3918084
CY2019Q1 alt Deemed Dividends
DeemedDividends
452925
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3885649
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2550231
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
214921
CY2020Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-17079
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
56739
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1750000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
214921
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
407714
CY2020Q1 us-gaap Depreciation
Depreciation
59505
CY2019Q1 us-gaap Depreciation
Depreciation
61277
CY2020Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
13851
CY2019Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
92744
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-24939
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
46081
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
973557
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-555808
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
214893
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-55928
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
911397
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-358107
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1175988
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
5284153
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
9519448
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2328561
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7187531
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25542
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46749
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
175226
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
231255
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7131528
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2097306
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-32435
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2097306
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3217671
CY2020Q1 us-gaap Interest Expense
InterestExpense
1885
CY2019Q1 us-gaap Interest Expense
InterestExpense
740
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
151569
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
185246
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2097306
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3245879
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3885649
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15110585
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9489765
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-18885
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-699942
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2312528
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
96713
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12699108
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
17176
CY2020Q1 alt Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
44385
CY2019Q1 alt Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
44202
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
3360633
CY2019Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
57896
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4347401
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2112887
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
13700000
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
7099263
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18131
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1226
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19390
CY2019Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3020
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6563216
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4246
CY2019Q1 us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
12668784
CY2020Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
56739
CY2020Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
39974
CY2019Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
30324
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10581975
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34353129
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44935104
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1050703
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
731935
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
318768
CY2020Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
13469670
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1031323
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
718095
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
313228
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
13450290
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
31452
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
26147
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
26147
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
26147
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
22241
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
186634
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
699154
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
429467
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
595884
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1183130
CY2020Q1 us-gaap Interest Payable Current
InterestPayableCurrent
6933
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
5047
CY2020Q1 alt Accrued Research And Development
AccruedResearchAndDevelopment
3499817
CY2020Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1423612
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
377757
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1045855
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.59
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.19
CY2020Q1 alt Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageExercisePrice
2.65
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y11M15D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y7M9D
CY2020Q1 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-12428
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
21644214
CY2019Q4 alt Accrued Research And Development
AccruedResearchAndDevelopment
1966111
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
266278
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
259449
CY2020Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
47628
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
61563
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5115694
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3904767
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1415970
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1484679
CY2020Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
10000
CY2019Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
10000
CY2020Q1 alt Economic Conditional Incentive Grants
EconomicConditionalIncentiveGrants
250000
CY2019Q4 alt Economic Conditional Incentive Grants
EconomicConditionalIncentiveGrants
250000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
115220
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
120196
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1791190
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1864875
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10384706
CY2020Q1 alt Number Of Warrants Exercised For Conversion Of Securities
NumberOfWarrantsExercisedForConversionOfSecurities
14500
CY2020Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10370206
CY2020Q1 alt Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageRemainingContractualTerm
P6Y29D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
940809
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
136786
CY2020Q1 alt Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOutstandingIntrinsicValue
804022
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
214921
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
407714
CY2020Q1 alt Non Cancellable Lease Maturity Period
NonCancellableLeaseMaturityPeriod
2022-12
CY2020Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
87599
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
61880
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1682248
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y29D
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.080
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
291366
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
393542
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
400198
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
407054
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
414116
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
138831
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2045107
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
362859
CY2020Q1 us-gaap Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority
IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
2890348
CY2020Q1 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-355531
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
21656642
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0

Files In Submission

Name View Source Status
0001564590-20-025123-index-headers.html Edgar Link pending
0001564590-20-025123-index.html Edgar Link pending
0001564590-20-025123.txt Edgar Link pending
0001564590-20-025123-xbrl.zip Edgar Link pending
alt-10q_20200331.htm Edgar Link pending
alt-20200331.xml Edgar Link completed
alt-20200331.xsd Edgar Link pending
alt-20200331_cal.xml Edgar Link unprocessable
alt-20200331_def.xml Edgar Link unprocessable
alt-20200331_lab.xml Edgar Link unprocessable
alt-20200331_pre.xml Edgar Link unprocessable
alt-ex311_10.htm Edgar Link pending
alt-ex312_6.htm Edgar Link pending
alt-ex321_9.htm Edgar Link pending
alt-ex322_11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending